0001273636-20-000013.txt : 20201218 0001273636-20-000013.hdr.sgml : 20201218 20201218173959 ACCESSION NUMBER: 0001273636-20-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201216 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Magovcevic-Liebisch Ivana CENTRAL INDEX KEY: 0001279281 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36370 FILM NUMBER: 201401694 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER NAME: FORMER CONFORMED NAME: Magovcevic Ivana DATE OF NAME CHANGE: 20040503 FORMER NAME: FORMER CONFORMED NAME: MARAVIC MAGOVCEVIC IVANA DATE OF NAME CHANGE: 20040209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-12-16 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001279281 Magovcevic-Liebisch Ivana C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE #10 ALACHUA FL 32615 1 0 0 0 Stock Option (right to buy) 4.72 2020-12-16 4 A 0 12000.0 0.0 A 2030-12-16 Common Stock 12000.0 12000.0 D The option becomes exercisable in equal monthly installments over one year from the date of grant. Exhibit 24 Power of Attorney filed herewith. /s/ Stacie Aarestad, Attorney-in-fact 2020-12-18 EX-24 2 attachment_1.htm MAGOVCEVIC-LIEBISCH POWER OF ATTORNEY

POWER OF ATTORNEY



     KNOW ALL BY THESE PRESENTS, that the undersigned hereby authorizes Hemmie Chang and Stacie Aarestad, each of Foley Hoag LLP, each acting singly, to execute for and on behalf of the undersigned, in the undersigned's capacity as a director of Applied Genetic Technologies Company (the "Company"), a Form ID, Forms 3, 4 and 5, and any amendments thereto, and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned's beneficial ownership of securities in the Company. The undersigned hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do personally present, with full power of substitution, resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney's-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.



     This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.



     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 8th day of December, 2020.



/s/ Ivana Magovcevic-Liebisch

Ivana Magovcevic-Liebisch